STAAR Surgical interim Co-CEO gets stock awards
STAAR Surgical interim Co-CEO and CFO Deborah J. Andrews reported equity compensation activity tied to performance stock units that vested on May 15, 2026.
Rhea-AI Filing Summary
STAAR Surgical interim Co-CEO and CFO Deborah J. Andrews reported equity compensation activity tied to performance stock units that vested on May 15, 2026. Two tranches of performance stock units under the 2025 PSU Program settled into 10,466 and 5,233 shares of common stock after the Compensation Committee certified performance results.
To cover tax obligations on these vestings, the company withheld 3,755 and 1,877 shares, reported as tax-withholding dispositions at about $32.07 per share. After these non‑market transactions, Andrews directly held 15,297 shares of STAAR Surgical common stock. The filing reflects routine compensation and tax withholding, not open‑market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Stock Units | 10,466 | $0.00 | $0.00 |
| Exercise | Performance Stock Units | 5,233 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 10,466 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 3,755 | $32.07 | $120K |
| Grant/Award | Common Stock | 5,233 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 1,877 | $32.07 | $60K |
Footnotes (4)
- F1. On May 15, 2026, the first tranche of 10,466 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with her new hire grant vested, of which 3,755 shares were withheld to satisfy taxes .
- F2. On May 15, 2026, the second tranche of 5,233 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her new hire grant vested, of which 1,877 shares were withheld to satisfy taxes.
- F3. Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
- F4. Represents the settlement of the second tranche of performance stock units awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
Key Figures
Key Terms
Performance Stock Units financial
2025 Performance Stock Unit Award Program financial
tax-withholding disposition financial
Compensation Committee financial
Rule 16b-3(d) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did STAAR Surgical (STAA) report for Deborah Andrews?
What is the 2025 PSU Program mentioned in STAAR Surgical’s Form 4?
Were Deborah Andrews’ original PSU grants previously reported by STAAR Surgical?
AI-generated analysis. How Rhea-AI works. Not financial advice.